. "Appendix B: Open Meeting Agendas." Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press, 2002.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
Appendix B
Open Meeting Agendas
Meeting I
April 3 and 4, 2000
The Foundry Building, Washington, D.C.
3 April 2000
10:00AM
Sponsor Presentation: Charge to the IOM and Welcoming Remarks
MG John S. Parker, M.D.,
Commanding General
U.S. Army Medical Research and Materiel Command
Overview of the Military Infectious Diseases Research Program
COL Charles H. Hoke, Jr., M.D.,
Research Area Director
Military Infectious Diseases Research Program
11:00AM
Break
11:15AM
Sponsor Presentation, continued
Overview of the DoD Research and Development (Acquisition) Model
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
Appendix B
Open Meeting Agendas
Meeting I
April 3 and 4, 2000
The Foundry Building, Washington, D.C.
3 April 2000
10:00AM
Sponsor Presentation: Charge to the IOM and Welcoming Remarks
MG John S. Parker, M.D.,
Commanding General
U.S. Army Medical Research and Materiel Command
Overview of the Military Infectious Diseases Research Program
COL Charles H. Hoke, Jr., M.D.,
Research Area Director
Military Infectious Diseases Research Program
11:00AM
Break
11:15AM
Sponsor Presentation, continued
Overview of the DoD Research and Development (Acquisition) Model
COL Rodney A. Michael, M.D.
Research Area Deputy Director
Military Infectious Diseases Research Program
OCR for page 120
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
Biologic Warfare Defense Research and Endemic Infectious Diseases
Research: Whence and why the dichotomy
COL John F. Glenn, Ph.D.
Deputy for Research and Development
U.S. Army Medical Research and Materiel Command
12:15PM
Lunch
1:15PM
Discussion with Sponsor:
Current challenges
Overview of the challenges to adequate vaccine strategy presented by industry and DoD policies and constraints
Overview of the regulatory parameters that currently affect military vaccine strategy
Discussion of what the U.S. Army seeks to gain from this committee report
Discussion of charge
2:15PM
Break, end of open session
Meeting II
June 19 and 20, 2000
The Foundry Building, Washington, D.C.
19 June 2000
10:00AM
Welcome and Introduction
Stanley Lemon, M.D., Chair
10:05AM
Examples of the Impact of Vaccine Preventable Infectious Disease:
Impact of Recent Adenovirus Outbreaks in Military Training Centers
CAPT Gregory Gray, M.D., M.P.H.
Director, DoD Center for Deployment Health Research
Naval Health Research Center, San Diego
Lt Col James Neville, M.D., M.P.H.
Chief, Force Health Protection and Surveillance Branch
U.S. Air Force Institute for Environment, Safety & Occupational
Health Risk Analysis
Brooks Air Force Base
OCR for page 121
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
Leonard N. Binn, Ph.D.
Supervisory Research Microbiologist, Department of Virus Diseases
Walter Reed Army Institute of Research
The Meningococcal Meningitis Situation, Military and Civilian
Juliette Morgan, M.D.
Medical Epidemiologist, Meningitis and Special Pathogens Branch
Centers for Disease Control and Prevention
John Brundage, M.D., M.P.H.
Senior Research Epidemiologist, Henry M. Jackson Foundation
Army Medical Surveillance Activity
Walter Reed Army Institute of Research
11:30AM
JVAP—Procurement Process for Vaccines for Biowarfare Defense
Richard B. Paul, M.A.
Acting Program Manager, Joint Vaccine Acquisition Program
12:00PM
Vaccine Development Success–Policy Failure
Adenovirus Vaccine: Successful Development
Franklin H. Top, Jr., M.D.
Executive Vice President and Medical Director, MedImmune
Adenovirus Vaccine: A Policy Failure
Joel Gaydos, M.D., M.P.H.
DoD Global Emerging Infections Surveillance & Response System,
Division of Preventive Medicine, Walter Reed Army Institute of Research
12:45PM
Lunch (and continued discussion)
1:30PM
Vaccine Research & Development: Priority Setting
DoD Requirements Generation and Acquisition
James H. Nelson, Ph.D.
Director, U.S. Army Medical Materiel Development Activity
Military Medical Surveillance of Infectious Disease
LTC Mark V. Rubertone, M.D., M.P.H.
Chief, Army Medical Surveillance Activity
U.S. Army Center for Health Promotion and Preventive Medicine
OCR for page 122
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
Medical Intelligence
Deborah G. Keimig, Ph.D.
Chief, Epidemiology and Environmental Health Division
Armed Forces Medical Intelligence Center, Fort Detrick
Priority Setting in Practice
COL Rodney A. Michael, M.D.
Deputy Director, Military Infectious Disease Research Program
Discussion
4:00PM
Open session ends
20 June 2000
7:30AM
Continental Breakfast
8:00AM
Review of Meeting Day 1 and Introduction of Day 2 Program
Stanley Lemon, M.D., Chair
8:20AM
Status of Limited Use Vaccines in the Military
LTC Phillip R. Pittman, M.D., M.P.H.
Senior Medical Scientist
U.S. Army Research Institute of Infectious Diseases
8:50AM
How Others (Try to) Make Limited Use Vaccine Development Work:
Food and Drug Administration
Karen Goldenthal, M.D.
Director, Division of Vaccines & Related Products Applications
National Institute of Allergy and Infectious Disease, National Institutes of Health
Carole A. Heilman, Ph.D.
Director, Division of Microbiology and Infectious Diseases
Centers for Disease Control and Prevention
James W. LeDuc, Ph.D.
Acting Director, Division of Viral and Rickettsial Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention
OCR for page 123
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
Industry Involvement in Federal Vaccine Development and Procurement Efforts
Thomas P. Monath, M.D.
Vice President, Research & Medical Affairs, OraVax Inc.
Discussion: Constraints Faced and Handled
How Might DoD Use These Approaches
11:45AM
Lunch—with concurrent discussion based on morning’s presentations
Open session ends
Meeting III
September 21 and 22, 2000
The Foundry Building, Washington, D.C.
21 September 2000
11:00AM
Welcome
Stanley Lemon, M.D., Chair
11:05AM
Adenovirus vaccine
MAJ Michael Dyer, M.S.
Office of the TRADOC Surgeon
William Howell
Deputy for Acquisition and Advanced Development
U.S. Army Medical Research and Materiel Command
12:00PM
Lunch
12:45PM
Vaccine production
Gary Nabel, M.D., Ph.D.
Director, NIH Vaccine Research Center
Jack Melling, Ph.D.
formerly with the Salk Institute and the Center for Applied Microbiology and Research
2:00PM
Priorities
LTC Brian G. Scott, M.D.
Clinical Consultant, Force Protection AMEDD Center and School
Directorate of Combat and Doctrine Development
OCR for page 124
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
COL John Frazier Glenn, Ph.D.
Deputy for Research and Development
U.S. Army Medical Research and Materiel Command
Discussion
Presenters along with:
COL Charles Hoke, Jr., M.D.
COL Rodney Michael, M.D.
4:00PM
Discussion
5:00PM
Adjourn for the day
Meeting IV
November 13 and 14, 2000
The Foundry Building, Washington, D.C.
13 November 2000
9:30AM
Continental breakfast in conference room
10:00AM
Review agenda, introduce speakers
10:10AM
Incentivizing limited use vaccine production: getting and keeping vaccines
Kevin L. Reilly
President, Wyeth Vaccines, Wyeth Pharmaceuticals
11:30AM
Public release of this committee’s interim report:
Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine
Availability: A Letter Report
Stanley Lemon, M.D., Chair
Adenovirus update
CDR Jeff Yund, M.D.
Division of Preventive Medicine and Occupational Health
U.S. Navy Bureau of Medicine and Surgery
12:30PM
Working lunch in conference room for committee, staff, and guests
1:30PM
Priority setting revisited (panel discussion)
COL John Frazier Glenn, Ph.D.
Deputy for Research and Development
U.S. Army Medical Research and Materiel Command
OCR for page 125
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
LTC Brian G. Scott, M.D.
Clinical Consultant, Force Protection
Directorate of Combat and Doctrine Development
AMEDD Center & School
COL Charles Hoke, Jr., M.D.
Director, Military Infectious Diseases Research Program
U.S. Army Medical Research and Materiel Command
3:00PM
Open session ends
Meeting V
Tuesday, February 27, 2001
The Foundry Building, Washington, D.C.
12:00PM
Working lunch in conference room for committee, staff, and guests
1:00PM
Setting vaccine priorities in DoD
Anna Johnson-Winegar, Ph.D.
Deputy Assistant to the Secretary of Defense
Counterproliferation and Chemical/Biological Defense
2:00PM
Open session ends
OCR for page 126
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
This page in the original is blank.
